Dynavax Technologies: Stellar Results, But Little Respect [Seeking Alpha]
Dynavax Technologies Corporation (DVAX)
Last dynavax technologies corporation earnings: 3/11 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.dynavax.com
Company Research
Source: Seeking Alpha
jarun011When I was a kid my parents moved a lot, but I always found themDynavax Technologies (NASDAQ:DVAXquarterly results, the stock has largely languished in 2022 on fears that its Covid adjuvant sales will fall sharply in 2023 as the Covid pandemic ebbs. However, the company is an intriguing 'sum of a parts' story that doesn't seem to be getting the proper respect from the markets right now. An analysis follows below.Seeking AlphaCompany Overview:Dynavax Technologies is based just outside of San Francisco. Its core long term product is HEPLISAV-B. This is a vaccine for Hepatitis B, which is rapidly taking market share as it is more effective (95% versus 81%) from the previous standard of care Entergis-B. It also can administer via two doses over a month rather and three doses over six months, thus achieving a much higher level of compliance. HEPLISAV-B was developed off Dynavax's toll-like receptor [TLR] immune modulation platform.November Company PresentationHowever, what is curre
Show less
Read more
Impact Snapshot
Event Time:
DVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DVAX alerts
High impacting Dynavax Technologies Corporation news events
Weekly update
A roundup of the hottest topics
DVAX
News
- Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024PR Newswire
- Dynavax Technologies Co. (NASDAQ: DVAX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Global Human Vaccines Market (2023-2028) [Yahoo! Finance]Yahoo! Finance
- Those who invested in Dynavax Technologies (NASDAQ:DVAX) five years ago are up 68% [Yahoo! Finance]Yahoo! Finance
- Dynavax Technologies: Still A Believer [Seeking Alpha]Seeking Alpha
DVAX
Earnings
- 2/22/24 - Beat
DVAX
Sec Filings
- 4/11/24 - Form ARS
- 4/11/24 - Form DEFA14A
- 4/11/24 - Form DEF
- DVAX's page on the SEC website